The above strongly suggests that the in vivo antitumor effect of IFN-β in malignant gliomas may be mediated, at least in part, via the angiogenesis inhibition rather than the antiproliferative activity on tumor cells. This evidence concerns the gene IFNB1 and neoplasm.